Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema

Acta Derm Venereol. 2018 Mar 13;98(3):373-375. doi: 10.2340/00015555-2839.
No abstract available

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Allopurinol / adverse effects
  • Allopurinol / therapeutic use*
  • Azathioprine / adverse effects
  • Azathioprine / blood
  • Azathioprine / therapeutic use*
  • Chronic Disease
  • Dermatitis, Atopic / diagnosis
  • Dermatitis, Atopic / drug therapy*
  • Drug Therapy, Combination
  • Eczema / diagnosis
  • Eczema / drug therapy*
  • Female
  • Foot Dermatoses / diagnosis
  • Foot Dermatoses / drug therapy*
  • Guanine Nucleotides / blood
  • Hand Dermatoses / diagnosis
  • Hand Dermatoses / drug therapy*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Mercaptopurine / analogs & derivatives
  • Mercaptopurine / blood
  • Middle Aged
  • Prospective Studies
  • Thionucleotides / blood
  • Time Factors
  • Treatment Outcome

Substances

  • Guanine Nucleotides
  • Immunosuppressive Agents
  • Thionucleotides
  • 6-thioguanylic acid
  • Allopurinol
  • 6-methylthiopurine
  • Mercaptopurine
  • Azathioprine